| Date | Title | Description |
| 09.09.2026 | Electronic Data Capture Systems Market to Reach USD 7.4 Billion by 2036 as Clinical Research Moves Toward Integrated Digital Data Management | Rockville, Maryland, United States – September 9, 2026 – The U.S. Food and Drug Administration’s guidance on electronic systems and records in clinical investigations emphasizes that computerized systems used to create, maintain, retrieve, ... |
| 28.05.2026 | Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors | Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, today announced the appointments of two non-executive board members, Frank Clyburn and Christopher (Ch... |
| 29.01.2026 | CB Insights Report: Digital Health Funding Hits $22.3B as 14 New Unicorns Emerge | What You Should Know
The Rebound: According to the new State of Digital Health 2025 report from CB Insights, digital health funding rose 19% YoY to $22.3B in 2025, driven by fewer, larger checks—average deal size jumped 29% to $20.3M.
The C... |
| 29.01.2026 | uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025 | Everest Group gives uMotif highest possible technology rating in eCOA market assessment; Chief Scientific Officer Florence Mowlem PhD leads C-Path publication of industry-wide Event-Driven eDiary best practices in Nature Digital Medicine; f... |
| 15.12.2025 | uMotif Chief Scientific Officer Leads Publication of Fundamental Work Detailing Industry-Wide Recommendations for Adopting Event-Driven eDiaries in Clinical Trials | On behalf of the Critical Path Institute (C-Path) Florence Mowlem PhD, led this much-needed project, providing 10 best practices for EDeD design and implementation to support clinical trial data capture, along with co-authors from Top 10 ph... |
| 29.10.2025 | Thermo Fisher приобретает американского поставщика клинических услуг Clario за $9,4 млрд | Компания Thermo Fisher в среду объявила о покупке частной компании Clario, специализирующейся на управлении данными, за сумму до $9,4 млрд в виде наличных и будущих выплат, что укрепит позиции фирмы в области цифрового здравоохранения и исс... |
| 02.07.2025 | Nordic Capital acquires majority stake in Arcadia | Photo: Martin Barraud/Getty Images
Editor's note: This article has been updated with a quote from Arcadia's president and CEO.
European private equity firm Nordic Capital has acquired a majority stake in data analytics company Arcadia throu... |
| 24.06.2025 | Progressing Beyond Exploratory Endpoints: The Value of Digital Biomarkers in Neuroscience Clinical Studies, Upcoming Webinar Hosted by Xtalks | www.clario.com/
In this free webinar, learn how the application of appropriate digital biomarkers can potentially reduce sample sizes and shorten timelines in neuroscience clinical studies when used within a holistic endpoint strategy. Atte... |
| 11.06.2025 | Oncology Clinical Development: Optimizing Value Through Implementation of a Patient-Centric, Holistic Endpoint Strategy, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, attendees will learn about the value of a well-planned electronic clinical outcome assessment (eCOA) strategy implemented early in a clinical development program, including how to comply with the latest ... |
| 08.05.2025 | Keys to Success in Clinical Trials: A Strategic Guide for Biotechs and Startups, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn how selecting the right clinical trial endpoints can enhance regulatory approval prospects, attract investors and ensure meaningful scientific outcomes. Attendees will gain insight into how biotech... |
| 18.04.2025 | The AI Revolution: Transforming Clinical Trials and DevOps with Precision | In the world of technology, change is the only constant. Today, artificial intelligence (AI) is not just a buzzword; it’s a catalyst for transformation. Two companies, Clario and Spacelift, are leading the charge in their respective fields,... |
| 17.04.2025 | Clario Collaborates with AWS to Push New Boundaries in Clinical Data Analysis with Generative AI | Clario’s Advanced AI-Powered Platform Streamlines Clinical Document Processing to Facilitate Faster Drug Development Timelines
Clario, a leading provider of endpoint data solutions to the clinical trial industry, today announced a multi-yea... |
| 01.04.2025 | From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, gain an overview of interstitial lung disease (ILD), including its key characteristics. Attendees will learn about endpoint selection considerations for ILD trials, including objective assessments of dis... |
| 02.03.2025 | The Tug-of-War Over AI: Copyright, Regulation, and the Future of Innovation | The landscape of artificial intelligence (AI) is shifting. Like tectonic plates, the forces of copyright and regulation are colliding, creating tremors that could reshape the future of technology. As AI continues to evolve, the debate over ... |
| 27.02.2025 | The Evolving Global AI Regulatory Landscape: Recent Developments and Practical Insights for Clinical Trials, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn about the current global AI regulatory landscape, including the new EU AI Act, FDA's recent updated draft guidance and emerging AI regulations in other parts of the world. Attendees will gain insig... |
| 04.02.2025 | GLP-1 Agonist Development: Endpoint Strategies to Help Differentiate Your Drug, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn strategies for leveraging innovative endpoint solutions to enhance the safety, efficacy and patient-focused value of GLP-1 clinical trials. The featured speakers will discuss how obesity and diabet... |
| 12.01.2025 | Navigating the Future of Drug Development: The Role of AI and Early Cardiac Safety Assessments | In the world of drug development, the stakes are high. Only a fraction of new drugs—about 10-15 percent—make it from the lab to the pharmacy shelf. The reasons for failure are often rooted in safety concerns, particularly regarding cardiac ... |
| 07.01.2025 | Innovation in QT Strategies: Leveraging Early-stage Safety Methodologies and AI to Maximize Your Opportunity for a TQT Waiver, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn why cardiac safety findings are amongst the leading reasons for safety-related termination of a drug development program. Attendees will learn how early-phase QT assessments in healthy volunteers p... |
| 22.10.2024 | Optimizing Obesity Trials: Integrating Diverse Endpoints to Holistically Assess Safety and Efficacy of GLP-1 Agonists and Beyond, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn about how obesity and diabetes drug development requires monitoring for hypoglycemia with a blood glucose meter (BGM) for regulatory submission. Attendees will learn how GLP-1 agonists and other ob... |
| 26.09.2024 | Psychiatric Drug Development: Digital Endpoint Solutions to Extract the Most Value from Your Clinical Study, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn how to improve data accuracy in psychiatric drug development with digital endpoints. Attendees will discover strategies to tackle placebo response and rater drift using science-led electronic clini... |
| 22.08.2024 | Advancing MS Clinical Trials: Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, our featured experts will explore recent studies demonstrating the practical applications and benefits of applying AI-based technologies to multiple sclerosis (MS) clinical trials. Topics of the discussi... |
| 24.06.2024 | Revolutionizing Ophthalmology Clinical Trials Through Enhanced Accessibility and Advanced AI-driven Analysis, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn how vendor-agnostic, multi-modality platforms improve regulatory compliance, transparency and workflow efficiency, particularly through AI-enabled real-time analysis and reporting in ophthalmology ... |
| 30.05.2024 | Advancing Alzheimer's Clinical Trial Endpoints: Imaging Biomarkers, COA Challenges, Movement Measures, and CV Risk, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, learn about the critical role of imaging biomarkers in characterizing patient eligibility, safety and therapeutic efficacy in Alzheimer's disease (AD) clinical trials. Attendees will gain insights into e... |
| 01.05.2024 | COGNIZANT REPORTS FIRST QUARTER 2024 RESULTS | Revenue of $4.8 billion declined 1.1% year-over-year, or declined 1.2% in constant currency1, which was above the high-end of our guidance range
Operating margin of 14.6%, flat year-over-year, and Adjusted Operating Margin1 of 15.1%, which ... |
| 30.04.2024 | A Holistic Approach to Parkinson's Disease Endpoint Data Collection: Efficacy, Safety and Quality of Life, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, attendees will learn about the complexities of Parkinson's disease (PD) endpoint data collection and obtain invaluable insights for improving patient outcomes and advancing therapeutic interventions. The... |
| 27.03.2024 | Going Beyond ATS/ERS 2019 Guidelines for Your Respiratory Clinical Trials, Upcoming Webinar Hosted by Xtalks | www.clario.com
In this free webinar, gain valuable insights into the future of data quality assessment in respiratory drug development and learn how to leverage these advancements to drive success in respiratory clinical trials. The feature... |
| 29.11.2023 | Clario’s New AI-Powered ECG Quality Score Tool Enhances Cardiac Safety Assessments | Clario’s new ECG Quality Score tool leverages a unique artificial intelligence and machine learning approach to reinforce cardiac safety data quality
It provides actionable insight to sponsors, enabling proactive remediation and peace of mi... |
| 16.08.2023 | AliveCor and Clario Partner to Offer Decentralized Clinical Trials- Focused Six-Lead ECG Solutions | What You Should Know:
Clario announced an expansion to its collaboration with AliveCor to enable trial participants to collect medical-grade six-lead ECG readings in the comfort of their own homes through KardiaRx, a clinical-trial-focused ... |
| 11.07.2023 | How the Recent FDA & EMA Regulations are Helping Advance and Enhance Electronic Clinical Outcome Assessments (eCOA/ePRO), Upcoming Webinar Hosted by Xtalks | Xtalks Life Science Webinars The webinar will include a comprehensive overview of the new/changed guidances, an exploration of how the new guidance could potentially advance and enhance the use of eCOA/ePRO, and a deeper look into the intri... |
| 30.05.2023 | New Frontiers in Respiratory Trials: AI, Lung Sounds, Remote Coaching and Alternate Endpoints, Upcoming Webinar Hosted by Xtalks | With the recent pandemic and the shift to a decentralized trial approach, trial participants are looking to test from home; however, without coaching and with standard overread timelines, there is a great risk of unusable data, retests and ... |
| 28.04.2023 | CNS (Central Nervous System) and Chronic Drug Trials: New Cardiac Safety Requirements, Upcoming Webinar Hosted by Xtalks | Further changes are coming to clinical trials, and drug developers need to be prepared to think about the cardiac safety of their drugs, beyond just QT/ECG evaluation.
TORONTO, Ontario, Canada (PRWEB) April 28, 2023
Drugs that are chronical... |
| 20.03.2023 | Safety and Tolerability in Oncology Trials: Cardiac Imaging, ECG and the Role for Patient-Reported Outcomes, Upcoming Webinar Hosted by Xtalks | Cardio-oncology, an evolving subspecialty focused specifically on the detection and management of these risks, has become an essential consideration within any oncology development program.
TORONTO (PRWEB) March 20, 2023
As clinical researc... |
| 09.03.2023 | New Options for TQT Waivers from First-in-Human and Oncology Phase I Studies, Upcoming Webinar Hosted by Xtalks | The speakers will dive into various case studies and look at the impacts of early-stage QT assessment given positive and negative results as well as the context of the drug development project.
TORONTO (PRWEB) March 09, 2023
Cardiac safety ... |
| 06.03.2023 | Clario, GI Reviewers and RSIP Vision Team Up to Present a New AI Solution to Advance Clinical Trials for Inflammatory Bowel Diseases | Clario, a leading healthcare research and technology company that generates the richest clinical evidence for the clinical trials industry and GI Reviewers, LLC Gastroenterology consultants and central readers, together with RSIP Vision, an... |
| 31.01.2023 | Paradigm Launches with $203M to Transform Clinical Trial Recruitment | A new startup co-incubated by ARCH Venture Partners and General Catalyst launched last week with $203 million in Series A funding.
The New York-based company, called Paradigm, is focused on improving patients’ access to clinical research. I... |
| 31.01.2023 | Clinical Outcome Assessments (COA): Diving Deeper, Applying Scientific Rigor and Good Instrument Design, Upcoming Webinar Hosted by Xtalks | This webinar takes a deep dive into how scientific rigor can be applied to COA even though they are subjective.
TORONTO, Ontario (PRWEB) January 31, 2023
The bedrock of a successful trial is a well-designed protocol with reliable measuremen... |
| 09.01.2023 | The Added Value of Biostatistics-Driven Randomization and Trial Supply Management System, Upcoming Webinar Hosted by Xtalks | As clinical trials become increasingly complex, biostatisticians become even more essential, providing the needed insight to understand protocol-specific randomization nuances and make optimal randomization decisions to improve trial outcom... |
| 01.11.2022 | eConsent — Driving Successful Adoption, Upcoming Webinar Hosted by Xtalks | Featured speakers from Clario will discuss the many misconceptions of eConsent including how some view it through the narrow prism of electronic signature, rather than focusing on the broader benefits of an informed electronic consent proce... |
| 13.10.2022 | How to Optimize Patient and Clinician Outcome Assessment Data (COA) in Early Phase Clinical Trials, Upcoming Webinar Hosted by Xtalks | Learn from industry authorities as they explore issues which impact data quality and patient burden for biotechs, pharma and CROs.
TORONTO (PRWEB) October 13, 2022
In this webinar, a team of expert panelists will answer key questions around... |
| 12.09.2022 | New Options for Avoiding a Dedicated TQT Study — The Impact of the New ICH E14/S7B Revisions, Upcoming Webinar Hosted by Xtalks | They will then share their impressions on the new opportunities that these revisions provide for drug development, as well as some thoughts on the as yet unresolved issues that will only become clarified over the next few years as regulator... |
| 30.08.2022 | Advances in Precision Motion and Imaging Clinical Trial Endpoints Collection for Parkinson’s Disease, Upcoming Webinar Hosted by Xtalks | The speakers will share clinical examples illustrating the selection and use of appropriate imaging studies and wearable sensors technology to capture performance outcome clinical outcome assessment (PerfO COA) in Parkinson’s disease and re... |
| 11.01.2022 | Clario and XingImaging expand partnership to deliver PET imaging clinical trials in China | BEIJING and PRINCETON, N.J., Jan. 11, 2022 /PRNewswire/ -- Clario, a technology company that delivers the leading endpoint technology solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tom... |
| 03.11.2021 | ERT and Bioclinica become Clario, The Leading Technology Solutions Company for Clinical Trial Innovation and Evidence | PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- ERT, the global clinical endpoint technology leader, today announced that following its early Q2 merger with Bioclinica, a technological and scientific leader in medical imaging, the combined compa... |
| - | Clinical trial software partnership forged for more efficient data tracking | Two software companies that track documents and data for clinical trials have forged a partnership to cut the amount of time it takes life science firms to submit applications for approval from the U.S. Food and Drug Administration.
The mov... |
